-
公开(公告)号:DE60117157T2
公开(公告)日:2006-09-21
申请号:DE60117157
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI J , BAUMEISTER A , DICKMAN A , DING HONG , DINGES JURGEN , FESIK W , HAJDUK J , KUNZER R , NETTESHEIM G , PETROS M , ROSENBERG H , SHEN WANG , THOMAS A , WENDT D
IPC: C07C311/51 , A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107
-
公开(公告)号:ES2258102T3
公开(公告)日:2006-08-16
申请号:ES01971244
申请日:2001-09-20
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , BRUNCKO MILAN , WANG XILU , AUGERI DAVID J , BAUMEISTER STEVEN A
IPC: A61K31/18 , A61K31/428 , A61K31/63 , A61K31/635 , A61P9/10 , A61P25/16 , A61P25/28 , A61P29/00 , A61P31/12 , A61P31/18 , A61P35/00 , A61P37/02 , C07C311/46 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/43 , C07C323/44 , C07C323/48 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/04 , C07D205/12 , C07D207/09 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/52 , C07D209/54 , C07D209/96 , C07D211/14 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/56 , C07D213/61 , C07D213/64 , C07D213/69 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/38 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D233/60 , C07D235/08 , C07D235/26 , C07D241/08 , C07D241/16 , C07D249/04 , C07D263/32 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/16 , C07D295/185 , C07D295/20 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D333/70 , C07D401/06 , C07D401/12 , C07D405/04 , C07D405/06 , C07D417/12 , C07D451/02 , C07D491/107 , C07D295/14
Abstract: Un compuesto de **fórmula** o una sal farmacéuticamente aceptable del mismo, donde A se selecciona entre el grupo constituido por fenilo y un anillo carbocíclico aromático de cinco o seis miembros donde de uno a tres átomos de carbono se reemplazan con un heteroátomo seleccionado entre el grupo constituido por nitrógeno, oxígeno y azufre, y donde A está sustituido a través de átomos de carbono del anillo; R1 se selecciona entre el grupo constituido por alquilo, haloalquilo, nitro y -NR5R6; R2 y R3 se seleccionan independientemente entre el grupo constituido por hidrógeno, alquenilo, alcoxi, alquilo, alquilsulfanilo, alquinilo, arilo, arilalcoxi, ariloxi, ariloxialcoxi, arilsulfanilo, arilsulfanilalcoxi, carboniloxi, cicloalquilalcoxi, cicloalquiloxi, halo, haloalcoxi, haloalquilo, heterociclo, (heterociclo)oxi, hidroxi, nitro y -NR5R6. R4 se selecciona entre el grupo constituido por arilo, arilalquenilo, arilalcoxi, cicloalquenilo, cicloalquilo, halo, heterociclo y (heterociclo)alcoxi; R5 yR6 se seleccionan independientemente entre el grupo constituido por hidrógeno, alquenilo, alcoxialquilo, alcoxicarbonilalquilo, alquilo, alquilsulfanilalquilo, alquilsulfonilalquilo, arilo, arilalquilo, arilalquilsulfanilalquilo, ariloxialquilo, arilsulfanilalquilo, arilsulfinilalquilo, arilsulfonilalquilo, carboxialquilo, cicloalquenilo, cicloalquenilalquilo, cicloalquilo, (cicloalquil)alquilo, cicloalquilcarbonilo, heterociclo, (heterociclo)alquilo, (heterociclo)sulfanilalquilo, hidroaralquilo, un grupo protector de nitrógeno y -N=CR7R8.
-
公开(公告)号:PL363637A1
公开(公告)日:2004-11-29
申请号:PL36363701
申请日:2001-11-30
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , GWALTNEY STEPHEN L II , HASVOLD LISA A , LI QUN , LI TOMGMEI , LIN NAN-HORNG , MANTEI ROBERT A , ROCKWAY TODD W , SHAM HING L , SULLIVAN GERARD M , TONG YUNSONG , WANG GARY T , WANG LE , WANG XILU , WANG WEIBO
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12
Abstract: Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
-
公开(公告)号:NZ526313A
公开(公告)日:2004-11-26
申请号:NZ52631301
申请日:2001-11-30
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , GWALTNEY STEPHEN L , HASVOLD LISA A , LI QUN , LI TOMGMEI , LIN NAN-HORNG , MANTEI ROBERT A , ROCKWAY TODD W , SHAM HING L , SULLIVAN GERARD M , TONG YUNSONG , WANG GARY T , WANG LE , WANG XILU , WANG WEIBO
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12
Abstract: A compound of formula (I); a pharmaceutical composition comprising the compound; the use of the compound in the preparation of a medicament for inhibiting farnesyltransferase in a patient in need of such treatment; and the use of the compound in the preparation of a medicament for treating cancer in a patient.
-
公开(公告)号:BG107908A
公开(公告)日:2004-01-30
申请号:BG10790803
申请日:2003-06-13
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKYO K , GWALTNEY II STEPHEN L , HASVOLD LISA A , LI QUN , LI TOMGMEI , LIN NAN-HORNG , MANTEI ROBERT A , ROCKWAY TODD W , SHAM HING L , SULLIVAN GERARD M , TONG YUNSONG , WANG GARY T , WANG LE , WANG XILU , WANG WEIBO
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12
Abstract: Substituted imidazoles and thiazoles having formula are used for inhibiting farnesyltransferase. Also disclosed are farnesylransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient. 10 claims
-
公开(公告)号:NO20032471L
公开(公告)日:2003-07-25
申请号:NO20032471
申请日:2003-05-30
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , GWALTNEY II STEPHEN L , HASVOLD LISA A , LI QUN , LI TOMGMEI , LIN NAN-HORNG , MANTEI ROBERT A , ROCKWAY TODD W , SHAM HING L , SULLIVAN GERARD M , TONG YUNSONG , WANG GARY T , WANG LE , WANG XILU , WANG WEIBO
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12
Abstract: Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
-
公开(公告)号:NO20032471D0
公开(公告)日:2003-05-30
申请号:NO20032471
申请日:2003-05-30
Applicant: ABBOTT LAB
Inventor: CLAIBORNE AKIYO K , GWALTNEY II STEPHEN L , HASVOLD LISA A , LI QUN , LI TOMGMEI , LIN NAN-HORNG , MANTEI ROBERT A , ROCKWAY TODD W , SHAM HING L , SULLIVAN GERARD M , TONG YUNSONG , WANG GARY T , WANG LE , WANG XILU , WANG WEIBO
IPC: A61K31/4164 , A61K31/4178 , A61K31/426 , A61K31/4439 , A61K31/4709 , A61P35/00 , A61P43/00 , C07D233/54 , C07D233/64 , C07D277/20 , C07D277/30 , C07D401/12 , C07D405/12 , C07D409/12 , C07D
Abstract: Substituted imidazoles and thiazoles having the formula are useful for inhibiting farnesyltransferase. Also disclosed are farnesyltransferase-inhibiting compositions and methods of inhibiting farnesyltransferase in a patient.
-
公开(公告)号:PE05042002A1
公开(公告)日:2002-06-20
申请号:PE0009402001
申请日:2001-09-19
Applicant: ABBOTT LAB
Inventor: MCCLELLAN WILLIAM , OOST THORSTEN , WANG XILU , BAUMEISTER STEVEN A , DING HONG , FESIK STEPHEN W , KUNZER AARON R , PETROS ANDREW M , WENDT MICHAEL D , THOMAS SHEELA A , SHEN WANG , ROSEMBERG SAUL H , NETTERSHEIM DAVID G , HAJDUK PHILIP J , DINGES JURGEN , DICKMAN DANIEL A , AUGERI DAVID J , BRUNCKO MILAN
IPC: C07C311/00 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07D203/10 , C07D205/12 , C07D207/24 , C07D207/40 , C07D207/404 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/22 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
CPC classification number: C07D207/404 , C07C311/51 , C07C317/28 , C07C323/12 , C07C323/17 , C07C323/25 , C07C323/30 , C07C323/37 , C07C323/58 , C07C323/60 , C07C2601/08 , C07C2601/14 , C07C2601/16 , C07C2601/18 , C07C2602/08 , C07C2602/10 , C07C2602/28 , C07C2602/42 , C07C2602/44 , C07C2603/74 , C07D203/10 , C07D205/12 , C07D207/24 , C07D209/08 , C07D209/96 , C07D211/44 , C07D211/70 , C07D211/74 , C07D213/61 , C07D213/70 , C07D213/71 , C07D215/14 , C07D215/227 , C07D215/48 , C07D217/04 , C07D221/20 , C07D231/12 , C07D235/08 , C07D235/26 , C07D241/16 , C07D249/04 , C07D263/56 , C07D263/58 , C07D277/62 , C07D277/64 , C07D295/13 , C07D295/155 , C07D295/185 , C07D295/205 , C07D295/215 , C07D295/26 , C07D307/14 , C07D317/54 , C07D333/28 , C07D333/68 , C07D401/06 , C07D401/12 , C07D405/04 , C07D417/12 , C07D451/02
Abstract: SE REFIERE A N-ACILSULFONAMIDAS DE FORMULA I DONDE A ES FENILO, ANILLO CARBOCICLICO AROMATICO DE 5-6 MIEMBROS; R1 ES ALQUILO, HALOALQUILO, NITRO, NR5R6; R2 Y R3 SON H, ALQUENILO, ALCOXI, ALQUILO, ALQUILSULFANILO, ALQUINILO, ARILO, ARILALCOXI, ENTRE OTROS; R4 ES ARILO, ARILALQUENILO, ARILALCOXI, ARILOXI, ARILOXIALCOXI, ENTRE OTROS; R5 Y R6 SON HIDROGENO, ALQUENILO, ALCOXIALQUILO, ENTRE OTROS; R5 Y R6 JUNTO A N FORMAN UN IMIDAZOLILO, MORFOLINILO, PIPERAZINILO, PIPERIDINILO, ENTRE OTROS; R15 ES H, ALQUILO, HALO. SON COMPUESTOS PREFERIDOS 4-((2,2-DIMETILCICLOPENTIL)AMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, 4-(CICLOHEXILAMINO)-N-((4´FLUORO(1,1'-BIFENIL)-4-IL)CARBONIL)-3-NITROBENCENSULFONAMIDA, ENTRE OTROS. SE REFIERE TAMBIEN A UNA COMPOSICION FARMACEUTICA. LOS COMPUESTOS MENCIONADOS SON PROMOTORES DE LA APOPTOSIS Y SON UTILES PARA EL TRATAMIENTO DEL CANCER
-
99.
公开(公告)号:CA2744711C
公开(公告)日:2017-06-27
申请号:CA2744711
申请日:2009-12-04
Applicant: ABBOTT LAB
Inventor: BRUNCKO MILAN , DING HONG , DOHERTY GEORGE A , ELMORE STEVEN W , HASVOLD LISA , HEXAMER LAURA , KUNZER AARON R , MANTEI ROBERT A , MCCLELLAN WILLIAM J , PARK CHANG H , PARK CHEOL-MIN , PETROS ANDREW M , SONG XIAOHONG , SOUERS ANDREW J , SULLIVAN GERARD M , TAO ZHI-FU , WANG GARY T , WANG LE , WANG XILU , WENDT MICHAEL D
IPC: C07D405/12 , A61K31/404 , A61P35/00 , C07D209/32 , C07D211/96 , C07D213/64 , C07D215/20 , C07D217/16 , C07D235/26 , C07D249/04 , C07D295/125 , C07D295/14 , C07D309/14 , C07D401/12
Abstract: Disclosed are compounds of formula (I) which inhibit the activity of anti-apoptotic BcI -2 or BcI -xL proteins, compositions containing the compounds and methods of treating diseases during which are expressed anti -aooptotic Bcl-2 protein.
-
公开(公告)号:CA2682356C
公开(公告)日:2016-06-14
申请号:CA2682356
申请日:2008-04-16
Applicant: ABBOTT LAB
Inventor: ELMORE STEVEN W , SOUERS ANDREW J , BRUNCKO MILAN , SONG XIAOHONG , WANG XILU , HASVOLD LISA A , WANG LE , KUNZER AARON R , PARK CHEOL-MIN , WENDT MICHAEL D , TAO ZHI-FU , MADAR DAVID
IPC: C07D209/42 , A61K31/404 , A61P35/00 , C07D401/12 , C07D413/06 , C07D417/04
Abstract: Compounds of formula (I) which inhibit the activity of anti-apoptotic McI-I protein, compositions containing the compounds, and methods of treating diseases involving overexpressed or unregulated McI-I protein are disclosed.
-
-
-
-
-
-
-
-
-